For patients with intramucosal esophageal adenocarcinoma (T1a EAC), endoscopic treatment (endoscopic resection, followed by ablation) is the current standard. This study focused on patients with
esophageal adenocarcinoma
esophageal adenocarcinoma
Endoscopic Therapy Is Highly Successful for Early Barrett’s Cancer
Endoscopic Therapy Is Highly Successful for Early Barrett’s Cancer
Genetic Risk Loci, Biomarkers, and Lifestyle Risk Factors in Barrett’s Esophagus and Cancer
Genetic Risk Loci, Biomarkers, and Lifestyle Risk Factors in Barrett’s Esophagus and Cancer
Genome-wide association studies (GWAS) involve scanning the DNA of a large cohort to identify any genetic variants associated with the disease in question. Previous GWAS
Upper GI Screening Endoscopy in Individuals With a Family History of Barrett’s Esophagus or Esophageal Cancer
Upper GI Screening Endoscopy in Individuals With a Family History of Barrett’s Esophagus or Esophageal Cancer
The incidence of esophageal adenocarcinoma (EAC) continues to increase and is still associated with a poor prognosis with a 5-year survival rate of 20%. The
